CN100506272C - 一种治疗银屑病的中药制剂 - Google Patents

一种治疗银屑病的中药制剂 Download PDF

Info

Publication number
CN100506272C
CN100506272C CNB2006100115180A CN200610011518A CN100506272C CN 100506272 C CN100506272 C CN 100506272C CN B2006100115180 A CNB2006100115180 A CN B2006100115180A CN 200610011518 A CN200610011518 A CN 200610011518A CN 100506272 C CN100506272 C CN 100506272C
Authority
CN
China
Prior art keywords
parts
rhizoma
chinese medicine
medicine preparation
zaocys
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CNB2006100115180A
Other languages
English (en)
Other versions
CN1857667A (zh
Inventor
王信锁
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beijing Jingui Chinese Medicine Research Institute Co Ltd
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CNB2006100115180A priority Critical patent/CN100506272C/zh
Publication of CN1857667A publication Critical patent/CN1857667A/zh
Application granted granted Critical
Publication of CN100506272C publication Critical patent/CN100506272C/zh
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

本发明涉及一种治疗银屑病的中药制剂,它以乌梢蛇、生地黄、大青叶、生槐花、金银花、白茅根、蝉蜕、土茯苓、莪术、白鲜皮、三棱、白花蛇舌草和冰片为原料。本发明具有清热解毒、祛风通络、凉血消斑的功效。治疗银屑病,具有见效快,疗效好,无毒副作用的优点。

Description

一种治疗银屑病的中药制剂
技术领域
本发明涉及一种治疗银屑病的中药制剂,是一种治疗银屑病以中草药为原料的中成药。属于中药领域。
背景技术
银屑病俗称牛皮癣,是一种常见的具有银白色鳞屑的、慢性、复发性、炎性皮肤病。中医又称为“松皮癣”或“白庀”。临床表现为红色丘疹或斑块上覆多层银白色鳞屑,并且除红斑、丘疹和鳞屑外,尚可有水疱、脓疱等皮损,以四肢伸面、头皮和背部较多。本病大多有明显的季节性,常在冬季发病或加剧,夏季自行痊愈或减轻,部分患者也可相反,但久病之后皮损仍不消退则季节性不明显。根据银屑病的临床特征,一般分为寻常型、脓疱型、关节病型及红皮病型四种类型。
祖国医学认为本病由外邪内侵,七情内伤,脾胃失和等因素导致内外合邪、热壅血络所致。此外,少数患者因调治不当,兼感毒邪,热毒流窜,入于营血,造成气血两燔,耗伤阴血之证。病久则经络阻隔,气血凝滞,故皮损厚硬。总之中医对本病的发病从内因、外因两方面考虑。外因为风、寒、湿、热、燥毒之邪,侵袭肌肤;内因则有禀赋血热、饮食不节、情感内伤等。现代医学对本病的病因病机尚未完全明了,各家说法不一。目前较为统一的认识是认为本病是有遗传、感染、代谢障碍、内分泌影响,免疫、神经精神等多种因素,通过多种途径引起的表皮细胞过度增生,角化不全及炎症反应。
中医对银屑病的辨证治疗常分为风热血燥、血虚风燥、湿热蕴结、火毒炽盛、气滞血瘀、风湿寒痹等症型进行治疗。西医治疗本病的方法很多,但大多数只能达到近期临床效果,而不能制止复发,且存在不同程度的毒副作用。
发明内容
本发明是在传统的中医辨证治疗的基础上结合现代最新科研成果研制而成的。本发明的目的是提供一种治疗银屑病的中药制剂,且具有疗效确切、安全方便、副作用小、价格低廉的特点。
本发明是由下述重量配比的原料制成的:
乌梢蛇 2.5~10份        生地黄 5~20份       大青叶 1.5~6份
金银花 2.5~10份        生槐花 1~4份        白茅根 1~4份
土茯苓 2.5~10份        白花蛇舌草 1.5~6份  白鲜皮 1.5~6份
莪术   0.5~2.5份       蝉蜕 0.5~2.5份      三棱   0.5~2.5份
冰片   0.1~1份。
本发明的优选配方各原料的重量配比是:
乌梢蛇  3~7份      生地黄  8~12份      大青叶 2~4份
金银花  3~7份      生槐花  1.5~2.5份   白茅根 1.5~2.5份
土茯苓  3~7份      白花蛇舌草 2~4份    白鲜皮 2~4份
莪术    1~2份      蝉蜕 1~2份          三棱   1~2份
冰片    0.3~0.7份。
本发明的最佳配方各原料的重量配比是:
乌梢蛇 5份     生地黄 10份      大青叶 3份
金银花 5份     生槐花 2份       白茅根 2份
土茯苓 5份     白花蛇舌草 3份   白鲜皮 3份
莪术   1.5份   蝉蜕 1.5份       三棱   1.5份
冰片   0.5份
本发明中的药物机理如下:
乌梢蛇  性味甘、平。归肝经。具有祛风,通络,止痉的功效。可治疗风湿顽痹,麻木拘挛,中风口眼歪斜,半身不遂,抽搐痉挛,破伤风症,麻风疥癣,瘰疬恶疮等。(季宇彬主编《抗癌中药药理与应用》黑龙江科学技术出版社1999年版第339页)。
生地黄  性味甘、寒。归心、肝、肾经。具有清热凉血,养阴,生津的功效。可治疗热病舌绛烦渴、阴虚内热、骨蒸劳热、内热消渴、吐血、衄血、发斑发疹等。(季宇彬主编《抗癌中药药理与应用》黑龙江科学技术出版社1999年版第514页)。
大青叶  性味苦、寒。归肝、心、胃经。具有清热解毒,凉血消斑的功效。可治疗温病热盛烦渴,发斑发疹,高热神昏,流行性感冒,急性传染性肝炎,菌痢,急性胃肠炎,急性肺炎,丹毒,吐血衄血,黄疸,咽喉肿痛,喉痹,痄腮,口疮,痈疽肿毒,流行性腮腺炎,流行性脑脊髓膜炎,流行性乙型脑炎,上呼吸道感染,钩虫,皮炎,无名热,钩端螺旋体,解铅毒等。(季宇彬主编《抗癌中药药理与应用》黑龙江科学技术出版社1999年版第129页)。
生槐花  性味苦、微寒。归肝、大肠经。具有凉血止血、清肝泻火的功效。可治疗肠风便血,痔血,血痢,尿血,血淋,崩漏,衄血,吐血,赤白痢下,肝热目赤,头痛眩晕,痈疽疮毒,并用于预防中风。(季宇彬主编《抗癌中药药理与应用》黑龙江科学技术出版社1999年版第1201页)。
金银花  性味甘、寒。归肺、心、胃经。具有清热解毒,凉散风热的功效。可治疗痈肿疔疮,瘰疬痔漏,喉痹,丹毒,热毒血痢,风热感冒,温病发热等。(季宇彬主编《抗癌中药药理与应用》黑龙江科学技术出版社1999年版第830页)。
白茅根  性味甘、寒。归肺、胃、膀胱经。具有凉血止血,消热利尿,镇静止痛,解酒毒的功效。可治疗热病烦渴、吐血、衄血、肺热喘急、胃热哕逆、淋病、小便不利、水肿、黄疸、急性肾炎水肿、泌尿系感染、高血压、热病烦渴、肺热、咳嗽等。(季宇彬主编《抗癌中药药理与应用》黑龙江科学技术出版社1999年版第463页)。
蝉蜕  性味甘、咸、寒。归肺、肝经。具有散风除热,利咽,透疹,退翳,解痉的功效。可治疗风热感冒,咽痛,音哑,麻疹不透,风疹瘙痒,目赤翳障,惊风抽搐,破伤风等。(季宇彬主编《抗癌中药药理与应用》黑龙江科学技术出版社1999年版第1254页)。
土茯苓  性味甘、淡、平。归肝、胃经。具有清热解毒,祛风湿,强筋骨,利关节,抗癌的功效。可治疗湿热疮毒,湿疹,风湿骨痛,肢体拘挛,杨梅恶疮,泌尿系统感染,梅毒,淋浊,淋症白带,消化不良,腹泻,脚气,疔疮,痈肿,瘰疬等。(季宇彬主编《抗癌中药药理与应用》黑龙江科学技术出版社1999年版第87页)。
莪术  性味苦、辛、温。归肝、脾经。具有行气破瘀,消积止痛,化聚消症,抗早孕,抗肿瘤的功效。可治疗心腹胀痛、症瘕积聚、宿食不消、肝脾肿大、血瘀腹痛、血滞经闭、宫颈糜烂、跌打损伤作痛等。(季宇彬主编《抗癌中药药理与应用》黑龙江科学技术出版社1999年版第995页)。
白鲜皮  性味苦咸、寒。归脾、胃经。具有祛风,燥湿,清热,解毒的功效。可治疗风热疮毒,疥癣,皮肤痒疹,风湿痹痛,黄疸等。《中药大辞典》第737页。
三棱  性味辛、苦、平。归肝、脾经。具有破血,行气,消积止痛的功效。可治疗症瘕积聚、气血凝滞,心腹疼痛,食积胀痛,胁下胀疼,经闭,痛经,产后淤血腹痛,跌打损伤,疮肿坚硬,肝脾肿大等。(季宇彬主编《抗癌中药药理与应用》黑龙江科学技术出版社1999年版第69页)。
白花蛇舌草  性味苦、甘、寒。归心、肝、胃三经。具有清热解毒,利尿消肿,活血止痛,抗菌消炎,抗癌的功效。可治疗肺热咳嗽、扁桃体炎、咽喉炎、痈肿疔疮、跌打损伤、泌尿系统感染、支气管炎、毒蛇咬伤等。(季宇彬主编《抗癌中药药理与应用》黑龙江科学技术出版社1999年版第476页)。
冰片  性味辛、苦、凉。归心、肺经。具有散郁火,去翳明目,开窍醒神,消肿止痛的功效。可治疗中风口噤、热病神昏、惊痫痰迷、气闭耳聋、喉痹、口疮、中耳炎、痈肿、痔疮、目赤翳膜、蛲虫病、急性扁桃体炎、霉菌性阴道炎、烧伤等。(季宇彬主编《抗癌中药药理与应用》黑龙江科学技术出版社1999年版第593页)。
本发明遵循中医“君臣佐使”的组方原则,用乌梢蛇、生地黄、土茯苓、白花蛇舌草为君药,用大青叶、金银花、生槐花、白茅根、白鲜皮、莪术和三棱为臣药,用蝉蜕和冰片为佐使药。诸药相和共具清热解毒、祛风通络、凉血消斑的功效,治疗银屑病,具有疗效确切,无毒副作用,服用方便,价格低廉的特点。
本发明的中药制剂,在制备成药剂时可加入药物可接受的载体,所述药物可接受的载体可以是:淀粉、蔗糖、乳糖、甘露糖醇、硅衍生物、纤维素类及其衍生物、藻酸盐、明胶、聚乙烯吡咯烷酮、甘油、土温80、琼脂、碳酸钙、碳酸氢钙、表面活性剂、聚乙二醇、环糊精、β-环糊精、磷脂类材料、高岭土、滑石粉、硬脂酸钙、硬脂酸镁等。
本发明的中药制剂可以是任何可药用的剂型,这些剂型包括:片剂、糖衣片剂、薄膜衣片剂、肠溶衣片剂、胶囊剂、硬胶囊剂、软胶囊剂、口服液、口含、颗粒剂、冲剂、丸剂、散剂、膏剂、丹剂、混悬剂、粉剂、溶液剂、注射剂、栓剂、软膏剂、硬膏剂、霜剂、喷雾剂、滴剂、贴剂。本发明的制剂,优选的中药制剂是口服剂型,如:片剂、胶囊剂、口服液、口含片、颗粒剂、冲剂、丸剂、散剂、混悬剂、粉剂、溶液剂、滴剂、滴丸剂。更优选的中药制剂是胶囊剂、片剂、颗粒剂。
本发明药物临床使用结果表明,有如下优点:
1、本发明选用的中草药各组份符合中华人民共和国药品管理法之规定,利用各味中药的综合作用治疗和预防银屑病,无化学甜味剂,对人体无毒无害。经动物急性毒性实验表明被实验的动物未见任何毒性反应,其主要脏器也无明显的改变,小鼠对本发明药物的最大耐受量为50g生药/kg,是临床人用量的187倍,药物安全可靠。
2、本发明无须煎煮,无苦涩感,药中富含蛋白质,葡萄糖,葡萄糖醛酸,挥发油,果胶,果糖,有机酸,卵磷脂,维生素,氨基酸,还含皂甙,植物甾醇和钙等多种微量元素,利于人体吸收,增强体质,且服用方便。
3、本发明不仅可有效的治疗银屑病,对银屑病的预防也有很好的作用,大大提高了患者的生存质量,有较高的治愈康复效果。
下面通过临床应用例进一步说明本发明药物对治疗银屑病的治疗效果。
银屑病疗效判定标准(《中药新药临床研究指导原则》郑筱萸主编中国医药
科技出版社2002年5月第一版第302页)。
1、临床痊愈中医临床症状、体征消失或基本消失;征候积分减少≥95%。
2、显效中医临床症状、体征明显改善,征候积分减少≥70%。
3、好转中医临床症状、体征均有好转,征候积分减少≥50%。
4、无效中医临床症状、体征均无明显改善,甚或加重,征候积分减少不足50%。
经临床试验结果如下;治疗银屑病患者78例,男性46例,女性32例,年龄为18~65岁。服用实施例1胶囊剂,每次2-10粒,每日三至四次,温开水送下,饭前半小时服用。一个月为一个疗程,连续服用三个疗程观察疗效。痊愈34例占43.6%,显效15例占19.2%,有效19例占24.3%,无效10例占12.8%,总有效率达87.2%。经三个疗程治疗后,患者红斑、丘疹和鳞屑等症状等均有明显改善。且病人无任何不良反应,三大常规化验及肝肾功能检测未发现异常。
具体实施方式
实施例1 胶囊剂 按下述重量称取原料:
乌梢蛇 5份      生地黄 10份    大青叶 3份
金银花 5份      生槐花 2份     白茅根 2份
土茯苓 5份      白花蛇舌草 3份 白鲜皮 3份
莪术   1.5份    蝉蜕 1.5份     三棱   1.5份
冰片   0.5份
制备方法是先取乌梢蛇和冰片干燥粉碎至120~200目细粉,再取生地黄、大青叶、生槐花、金银花、白茅根、蝉蜕、土茯苓、莪术、白鲜皮、三棱和白花蛇舌草加水煎煮两次,第一次1.5~2小时,第二次0.5~1小时,合并两次煎液,滤过,滤液浓缩至80度~85度时,相对密度1.08~1.10的清膏,加入乙醇使清膏含醇量达70%,静置24小时,回收乙醇,在50度~55度时浓缩至相对密度1.30~1.32的清膏,再将清膏与乌梢蛇和冰片细粉混匀,干燥,粉碎成细粉,装入胶囊。每粒装0.3克,通常饭前半小时口服,温开水送下,一次2~10粒,一日三至四次,一个月为一个疗程。
实施例2 片剂 按下述重量称取原料:
乌梢蛇 5份     生地黄 10份    大青叶 3份
金银花 5份     生槐花 2份     白茅根 2份
土茯苓 5份     白花蛇舌草 3份 白鲜皮 3份
莪术   1.5份   蝉蜕 1.5份     三棱   1.5份
冰片   0.5份
制备方法是先取乌梢蛇和冰片干燥粉碎至120~200目细粉,再取生地黄、大青叶、生槐花、金银花、白茅根、蝉蜕、土茯苓、莪术、白鲜皮、三棱和白使清膏含醇量达70%,静置24小时,回收乙醇,在50度~55度时浓缩至相对密度1.30~1.32的清膏,再将清膏与乌梢蛇和冰片细粉混匀,干燥,粉碎成细粉,加入适量淀粉、乙醇制粒,干燥后,加入适量硬脂酸镁,压片,包糖衣即得。通常饭前半小时口服,温开水送下,一次2~10片,一日三至四次,一个月为一个疗程。
实施例3 颗粒剂 按下述重量称取原料:
乌梢蛇 5份      生地黄 10份      大青叶 3份
金银花 5份      生槐花 2份       白茅根 2份
土茯苓 5份      白花蛇舌草 3份   白鲜皮 3份
莪术   1.5份    蝉蜕 1.5份       三棱   1.5份
冰片   0.5份
制备方法是先取乌梢蛇和冰片干燥粉碎至120~200目细粉,再取生地黄、大青叶、生槐花、金银花、白茅根、蝉蜕、土茯苓、莪术、白鲜皮、三棱和白花蛇舌草加水煎煮两次,第一次1.5~2小时,第二次0.5~1小时,合并两次煎液,滤过,滤液浓缩至80度~85度时,相对密度1.08~1.10的清膏,加入乙醇使清膏含醇量达70%,静置24小时,回收乙醇,在50度~55度时浓缩至相对密度1.30~1.32的清膏,再将清膏与乌梢蛇和冰片细粉混匀,干燥,粉碎成细粉,加入适量蔗糖和可溶性淀粉,乙醇制粒,干燥后装袋即得。通常饭前半小时温开水冲服,一次1~3袋,一日三至四次,一个月为一个疗程。

Claims (3)

1、一种治疗银屑病的中药制剂,其特征在于它是由下述重量配比的原料药制成的:
乌梢蛇  2.5~10份    生地黄   5~20份    大青叶   1.5~6份
金银花  2.5~10份    生槐花   1~4份     白茅根   1~4份
土茯苓  2.5~10份    白花蛇舌草 1.5~6份 白鲜皮   1.5~6份
莪术    0.5~2.5份   蝉蜕     0.5~2.5份 三棱     0.5~2.5份
冰片    0.1~1份。
2、根据权利要求1所述的一种治疗银屑病的中药制剂,其中各原料药的重量配比是:
乌梢蛇   3~7份    生地黄  8~12份    大青叶   2~4份
金银花   3~7份    生槐花  1.5~2.5份 白茅根   1.5~2.5份
土茯苓   3~7份    白花蛇舌草 2~4份  白鲜皮   2~4份
莪术     1~2份    蝉蜕    1~2份     三棱     1~2份
冰片     0.3~0.7份。
3、根据权利要求1所述的一种治疗银屑病的中药制剂,其中各原料药的重量配比是:
乌梢蛇  5份      生地黄  10份      大青叶  3份
金银花  5份      生槐花  2份       白茅根  2份
土茯苓  5份      白花蛇舌草 3份    白鲜皮  3份
莪术    1.5份    蝉蜕    1.5份     三棱    1.5份
冰片    0.5份。
CNB2006100115180A 2006-03-20 2006-03-20 一种治疗银屑病的中药制剂 Expired - Fee Related CN100506272C (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNB2006100115180A CN100506272C (zh) 2006-03-20 2006-03-20 一种治疗银屑病的中药制剂

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNB2006100115180A CN100506272C (zh) 2006-03-20 2006-03-20 一种治疗银屑病的中药制剂

Publications (2)

Publication Number Publication Date
CN1857667A CN1857667A (zh) 2006-11-08
CN100506272C true CN100506272C (zh) 2009-07-01

Family

ID=37296655

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB2006100115180A Expired - Fee Related CN100506272C (zh) 2006-03-20 2006-03-20 一种治疗银屑病的中药制剂

Country Status (1)

Country Link
CN (1) CN100506272C (zh)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100522137C (zh) * 2007-02-16 2009-08-05 遵义医学院附属医院 治疗银屑病的乳膏剂及其制备方法

Also Published As

Publication number Publication date
CN1857667A (zh) 2006-11-08

Similar Documents

Publication Publication Date Title
CN102357146B (zh) 一种治疗脚气的中药
CN100415265C (zh) 一种治疗湿疹的中药制剂
CN103830639A (zh) 一种治疗湿疹的药物及其制备方法
CN100546618C (zh) 一种治疗银屑病的中药制剂
CN100415278C (zh) 一种治疗湿疹的中药制剂
CN100415288C (zh) 一种治疗银屑病的中药制剂
CN101028491B (zh) 一种治疗带状疱疹的中药制剂
CN102579975B (zh) 一种治疗银屑病的中药混合物
CN100431578C (zh) 一种治疗前列腺增生的中药制剂
CN100506272C (zh) 一种治疗银屑病的中药制剂
CN100415277C (zh) 一种治疗银屑病的中药制剂
CN100571751C (zh) 一种治疗银屑病的中药制剂
CN100571725C (zh) 一种治疗坐骨神经痛的中药制剂
CN101095905A (zh) 一种治疗银屑病的中药制剂
CN101028421B (zh) 一种治疗慢性肾衰的中成药
CN100546623C (zh) 一种治疗银屑病的中药制剂
CN101912513B (zh) 一种治疗湿疹的中药制剂
CN105106574A (zh) 一种中药组合物在治疗不孕不育中的应用
CN100450537C (zh) 一种治疗前列腺增生的中药制剂
CN101085249A (zh) 一种治疗月经先期的中药
CN100382831C (zh) 一种治疗湿疹的中药制剂
CN100486629C (zh) 一种治疗银屑病的中药制剂
CN101069736A (zh) 一种治疗银屑病的中药制剂
CN105434874A (zh) 一种治疗毛囊炎的药物及其制备方法
CN103611098B (zh) 一种治疗皮肤瘙痒的中药

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
ASS Succession or assignment of patent right

Owner name: BEIJING SINO-US INNOVATION INSTITUTE OF INTERNATIO

Free format text: FORMER OWNER: WANG XINSUO

Effective date: 20110413

C41 Transfer of patent application or patent right or utility model
COR Change of bibliographic data

Free format text: CORRECT: ADDRESS; FROM: 100072 CHANGXINDIAN HOSPITAL, FENGTAI DISTRICT, BEIJING TO: 100076 NO. 10, EAST ALLEY 6, NORTH AREA, MINSHENG ROAD, VILLAGE 4, XIHONGMEN TOWN, DAXING DISTRICT, BEIJING

TR01 Transfer of patent right

Effective date of registration: 20110413

Address after: 100076, No. six, No. 10, North East Road, Minsheng Road, fourth village, Xihongmen Town, Beijing, Daxing District

Patentee after: Beijing Sino US Joint Institute of innovation and international difficult diseases

Address before: 100072 Beijing Fengtai Changxindian Hospital

Patentee before: Wang Xinsuo

ASS Succession or assignment of patent right

Owner name: CHEN YUTANG

Free format text: FORMER OWNER: BEIJING SINO-US INNOVATION INSTITUTE OF INTERNATIONAL STUBBORN DISEASES

Effective date: 20120316

C41 Transfer of patent application or patent right or utility model
C53 Correction of patent for invention or patent application
CB03 Change of inventor or designer information

Inventor after: Chen Yutang

Inventor before: Wang Xinsuo

COR Change of bibliographic data

Free format text: CORRECT: INVENTOR; FROM: WANG XINSUO TO: CHEN YUTANG

TR01 Transfer of patent right

Effective date of registration: 20120316

Address after: 100076, Beijing Town, Daxing District Town, Xihongmen, four village, Minsheng Road, North East six, No. 10

Patentee after: Chen Yutang

Address before: 100076, No. six, No. 10, North East Road, Minsheng Road, fourth village, Xihongmen Town, Beijing, Daxing District

Patentee before: Beijing Sino US Joint Institute of innovation and international difficult diseases

C56 Change in the name or address of the patentee
CP02 Change in the address of a patent holder

Address after: 100076, Beijing, Xihongmen Town, fourth village, Minsheng Road, North East six, No. 10, Beijing Sino US joint innovation and Research Institute of international difficult diseases, Daxing District

Patentee after: Chen Yutang

Address before: 100076, Beijing Town, Daxing District Town, Xihongmen, four village, Minsheng Road, North East six, No. 10

Patentee before: Chen Yutang

ASS Succession or assignment of patent right

Owner name: BEIJING SINO-US JOINT INTERNATIONAL DISEASES RESEA

Free format text: FORMER OWNER: CHEN YUTANG

Effective date: 20120417

C41 Transfer of patent application or patent right or utility model
TR01 Transfer of patent right

Effective date of registration: 20120417

Address after: 100076, Beijing Daxing District Xihongmen town fourth village Minsheng Road North East six 10, Beijing Sino US Joint Innovation Institute of international difficult disease Chen Zhonghua Dean

Patentee after: Beijing Sino US Joint Institute of innovation and international difficult diseases

Address before: 100076, Beijing, Xihongmen Town, fourth village, Minsheng Road, North East six, No. 10, Beijing Sino US joint innovation and Research Institute of international difficult diseases, Daxing District

Patentee before: Chen Yutang

ASS Succession or assignment of patent right

Owner name: BEIJING CHINESE AND FOREIGN XINCHUANG INTERNATIONA

Free format text: FORMER OWNER: BEIJING SINA-AMERICA INNOVATION UNITED INTERNATIONAL DIFFICULT DISEASE RESEARCH INSTITUTE

Effective date: 20121015

Owner name: BEIJING SINA-AMERICA INNOVATION UNITED INTERNATION

Effective date: 20121015

C41 Transfer of patent application or patent right or utility model
COR Change of bibliographic data

Free format text: CORRECT: ADDRESS; FROM: 100076 DAXING, BEIJING TO: 100012 CHAOYANG, BEIJING

TR01 Transfer of patent right

Effective date of registration: 20121015

Address after: 100012 Beijing city Chaoyang District Shangli Road No. 201 Beijing Chinese New International Medical Research Institute

Patentee after: Beijing new China International Pharmaceutical Research Institute

Patentee after: Beijing Sino US Joint Institute of innovation and international difficult diseases

Address before: 100076, Beijing Daxing District Xihongmen town fourth village Minsheng Road North East six 10, Beijing Sino US Joint Innovation Institute of international difficult disease Chen Zhonghua Dean

Patentee before: Beijing Sino US Joint Institute of innovation and international difficult diseases

ASS Succession or assignment of patent right

Free format text: FORMER OWNER: BEIJING SINA-AMERICA INNOVATION UNITED INTERNATIONAL DIFFICULT DISEASE RESEARCH INSTITUTE

Effective date: 20121127

Owner name: BEIJING JINKUI CHINESE MEDICAL RESEARCH INSTITUTE

Free format text: FORMER OWNER: BEIJING CHINESE AND FOREIGN XINCHUANG INTERNATIONAL MEDICAL RESEARCH INSTITUTE

Effective date: 20121127

C41 Transfer of patent application or patent right or utility model
C53 Correction of patent for invention or patent application
CB03 Change of inventor or designer information

Inventor after: Lin Wanshuo

Inventor before: Chen Yutang

COR Change of bibliographic data

Free format text: CORRECT: INVENTOR; FROM: CHEN YUTANG TO: LIN WANSHUO

Free format text: CORRECT: ADDRESS; FROM: 100012 CHAOYANG, BEIJING TO: 100010 DONGCHENG, BEIJING

TR01 Transfer of patent right

Effective date of registration: 20121127

Address after: 100010, No. 3-1, building 3, Beijing Hutong, Dongcheng District, China

Patentee after: Beijing Jingui Chinese Medicine Research Institute Co. Ltd.

Address before: 100012 Beijing city Chaoyang District Shangli Road No. 201 Beijing Chinese New International Medical Research Institute

Patentee before: Beijing new China International Pharmaceutical Research Institute

Patentee before: Beijing Sino US Joint Institute of innovation and international difficult diseases

DD01 Delivery of document by public notice

Addressee: Lin Wanshuo

Document name: Notice of termination of patent

DD01 Delivery of document by public notice
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20090701

Termination date: 20200320

CF01 Termination of patent right due to non-payment of annual fee